Open access · CC-BY
via OpenAlex
Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis
Marta Bueno, Jazmín Calyeca, Mauricio Rojas, Ana L. Mora
Redox Biology · 2020 · ▲ 285 citations
Abstract
Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease of unknown etiology. It is characterized by deposition of extracellular matrix proteins, like collagen and fibronectin in the lung interstitium leading to respiratory failure. Our understanding of the pathobiology underlying IPF is still incomplete; however, it is accepted that aging is a major risk factor in the disease while growing evidence suggests that the mitochondria plays an important role in the initiation and progression of pulmonary fibrosis. Mitochondria dysfunction and metabolic reprogramming had been identified in different IPF lung cells (alveolar epithelial cells, fibroblasts, and macrophages) promoting low resilience and increasing susceptibility to activation of profibrotic responses. Here we summarize changes in mitochondrial numbers, biogenesis, turnover and associated metabolic adaptations that promote disrepair and fibrosis in the lung. Finally, we highlight new possible therapeutic approaches focused on ameliorate mitochondrial dysfunction(definition).
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.redox.2020.101509
- Canonical
- link ↗
- Fetched
- 2026-09-21 MST
Cite this
APA
Bueno, M., Calyeca, J., Rojas, M., & Mora, A.L. (2020). Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis. <em>Redox Biology</em>. https://doi.org/10.1016/j.redox.2020.101509
Vancouver
Bueno M, Calyeca J, Rojas M, Mora AL. Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis. Redox Biology. 2020. doi:10.1016/j.redox.2020.101509.
BibTeX
@article{marta2020Mitoch,
title = {Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis},
author = {Marta Bueno and Jazmín Calyeca and Mauricio Rojas and Ana L. Mora},
journal = {Redox Biology},
year = {2020},
doi = {10.1016/j.redox.2020.101509},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Medicine 2018
Open access · CC-BY
Idiopathic Pulmonary Fibrosis: Aging, Mitochondrial Dysfunction, and Cellular Bioenergetics
Annals of the American Thoracic Society 2016
Citation only
Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis
Journal of Clinical Investigation 2017
Open access · OA
Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis
American Journal of Physiology-Cell Physiology 2023
Preprint · OA
The aged extracellular matrix and the profibrotic role of senescence-associated secretory phenotype
International Journal of Molecular Sciences 2020
Open access · CC-BY
Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis
Oxidative Medicine and Cellular Longevity 2021
Open access · CC-BY